骨肉瘤
转录组
生物标志物
医学
生物
计算生物学
癌症研究
生物信息学
肿瘤科
内科学
基因
基因表达
生物化学
作者
Ryan A. Lacinski,Sebastian A. Dziadowicz,Clark Roth,Li Ma,Vincent K. Melemai,Brody Fitzpatrick,Edwin O. Chaharbakhshi,Tanya Heim,Ines Lohse,Karen E. Schoedel,Gangqing Hu,Nicolás J. Llosa,Kurt R. Weiss,Brock A. Lindsey
标识
DOI:10.3389/fonc.2024.1417459
摘要
The large-scale proteomic platform known as the SomaScan® assay is capable of simultaneously measuring thousands of proteins in patient specimens through next-generation aptamer-based multiplexed technology. While previous studies have utilized patient peripheral blood to suggest serum biomarkers of prognostic or diagnostic value in osteosarcoma (OSA), the most common primary pediatric bone cancer, they have ultimately been limited in the robustness of their analyses. We propose utilizing this aptamer-based technology to describe the systemic proteomic milieu in patients diagnosed with this disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI